Support and resistance (2 touches)
A price that has stopped the move before tends to stop it again: the level where price hit and turned back is where it should hit and turn back once more, and that is why it serves as an entry point.
Measured in crypto — Binance spot · 540 pairs, delisted ones included · 0.2% per round trip
- ✓invariance
- ✗costs
- ✗placebo
- ✗benchmark
- ✗out of sample
- ✓multiple testing
At its worst the account was worth 95% less than its own best previous moment, and it spent 3,146 days below that peak.
What was measured
How many of those trades actually count
What it paid, before any deductions
Why it did not pass — it died here · the broker's fee
What would have happened to the money
The account would not fit every signal
What this result does NOT say
- One market, one universe
- Measured on 538 spot cryptocurrency pairs, delisted ones included. It says nothing about futures, equities or indices, nor about how the same technique behaves in another market.
- One window of time, not every window
- The measured period runs from 2017-08-17 to 2026-07-28. A market moves through regimes, and a technique can work in one and fail in another — the card measures the regimes that fit inside this window, not the ones still to come.
- One cost structure
- The cost charged is 0.10% per leg, in and out. Anyone paying more than that gets a worse result, and anyone paying less gets a better one — the verdict holds for this fee.
- One exit rule
- The trade was closed by: the auditor's fixed horizon (10 bars). The same entry measured with a different exit is a different strategy, and can earn a different verdict — it happens in this archive.
- The number of trades is not the sample size
- There are 52,372 trades, but only 29 independent market episodes: a single move fires the technique across dozens of assets at once, and counting those as separate observations inflates any result. It is the smaller number that governs the arithmetic. With 29 episodes, what the data supports is a range from -1.68% to +0.04% per trade — the published average is the centre of it, not the exact measurement.
- Daily bars
- Measured at the daily close. Nothing here measures what happens inside the day, and an intraday technique is not auditable with this data.
Numbers and reproducibility
The six controls
| control | status | t | threshold | episodes |
|---|---|---|---|---|
| invariance | passed | — | — | — |
| costs | failed | -2.42 | 2.05 | 29 |
| placebo | failed | -1.77 | 2.05 | 29 |
| benchmark | failed | — | — | — |
| out of sample | failed | — | — | — |
| multiple testing | passed | — | — | — |
- invariance52372 signals across 750934 barsconcentration: +46.45% of the profit sits in the top 5% of trades — with the dates shuffled, +48.84% (fails above +50.00%)
- costsgross -0.817% · cost 0.200% · net -1.017% (t=-2.42)
- placeboactual -1.017% · placebo -0.221% · excess -0.796% ± 0.449% (t=-1.77 against a threshold of 2.05, 29 real groups, 2,618,600 sham dates, draw error ±0.011%)
- benchmarktechnique -1.02% · buy and hold (same horizon) +0.03% · excess -1.04%
- out of sampleasset half A: -1.134% (t=-0.47, 29 episodes) · asset half B: -0.912% (t=-2.85, 28 episodes) · liquid half (>= US$ 2,066,613/day): -0.932% (t=-2.37, 29 episodes) · illiquid half: -1.136% (t=-0.73, 27 episodes) · period 1/4 (2017-10-02 a 2022-06-21): -2.412% (t=-4.37, 16 episodes) · period 2/4 (2022-06-22 a 2023-10-04): -1.131% (5 episodes — too small, does not count) · period 3/4 (2023-10-05 a 2025-06-09): +0.177% (7 episodes — too small, does not count) · period 4/4 (2025-06-10 a 2026-07-18): -0.708% (4 episodes — too small, does not count)
- multiple testing1 variation(s) tested · t=-2.42 across 29 episodes (equivalent to t=-2.32) · p≈0.0205 · false positives expected by chance ≈ 0.02
Equity — outside the six controls, and here is why
The t of the trade series is invariant to bet size: 0.5%, 1% and 3% agree to the sixth decimal. Nothing here moves the verdict — it moves what the account would have lived through.
- risking 1.0% per trade
- ×0.05
- worst drawdown from the peak
- −95%
- days below the previous peak
- 3,146
- signals refused for lack of capital
- 56%
- paths where the account halved (out of 12)
- 12
Reproducibility
- period
- 2017-08-17 to 2026-07-28
- assets that traded
- 538
- variations tested before this one
- 1
- gross per trade
- −0.82%
- net per trade
- −1.02%
- exit rule
- the auditor's fixed horizon (10 bars)
- horizon bars
- 10
- fee per leg
- 0.001
- episode days
- 112
- seed
- 20260728
- open parameters
- touches, tolerance, max age — the source does NOT specify; the published value was chosen in the translation and is not a claim of the technique. ⚠️ NOT SWEPT: this card measures ONE cell of a parameter space, and control 6 was given 1 attempt.
- touches
- 2
- tolerance
- 0.03
- max age
- 120
Binance spot klines (delisted pairs included) · collected from 2026-07-27 23:31 to 2026-08-03 10:49 · 540 assets · 750,934 bars · 2017-08-17 to 2026-07-28
Hypothesis, filed before the result
I expect it to DIE, and to die at cost before anything else. The family fires on 7% to 11% of the bars — a round trip every 9 to 14 bars, against one per lunar cycle in the technique audited today —, and at 0.1% per side that is a drag of tens of percent a year. Add that support and resistance is the most universally watched technique there is: if there were an edge at a level everyone can see, it would be the first to be arbitraged away. What would contradict me: a net edge that survives the placebo and the benchmark. And there is an intermediate result that also half contradicts me — a clear GROSS edge dying only at cost would be a real signal, and then the technique is good and it is the broker that eats it.
the filing date is not in this audit's record
The original, as it was filed
Espero que MORRA, e que morra no custo antes de qualquer outra coisa. A família dispara em 7% a 11% das velas — uma ida e volta a cada 9 a 14 velas, contra uma por ciclo lunar na técnica auditada hoje —, e a 0,1% por lado isso é arrasto de dezenas de por cento ao ano. Some-se que suporte e resistência é a técnica mais universalmente olhada que existe: se houvesse vantagem num nível que todo mundo enxerga, ela seria a primeira a ser arbitrada. O que me contraria: vantagem líquida que sobreviva ao placebo e ao benchmark. E há um resultado intermediário que também me contraria pela metade — vantagem BRUTA clara morrendo só no custo seria sinal real, e aí a técnica é boa e a corretora é que come.
Pre-registration exists to keep prediction apart from rationalisation: written after the number, every hypothesis is right.
This claim has been audited once — there is no history to compare against.